SIS
NEUTRALScience in Sport Shares Suspended Pending Announcement
The retailer has temporarily suspended trading in its shares, pending an upcoming announcement.
Science in Sport
33.50GBX
0.00%
Market Cap
77.13M
Volume
39.6k
3% of avg
P/E Ratio
-0.24
EPS (TTM)
-1.4
Beta
0.27
Day Range
33.52p - 33.95p
52 Week Range
17.00p33.50p34.00p
33.50p
Upcoming Events
30 June 2025
Annual General Meeting
SIS
NEUTRALScience in Sport Announces Notice of Annual General Meeting
The retailer has announced the date for its upcoming Annual General Meeting, though it is unlikely the meeting will take place due to a proposed acquisition.
SIS
NEUTRALScience in Sport Provides Update on Irrevocables
The retailer provides an update on the irrevocable undertakings received by the bidder in relation to the recommended cash acquisition.
SIS
NEUTRALScience in Sport Receives Further Irrevocable Undertakings for Acquisition
The retailer provides an update on the recommended cash acquisition, including additional irrevocable undertakings received from a major shareholder.
SIS
GOODScience in Sport Publishes 2024 Annual Report
The premium performance nutrition company has published its 2024 Annual Report, providing shareholders access to detailed financial and operational information.
SIS
BADScience in Sport Reports Mixed Results: Revenue Down 17%, EBITDA Doubles
The sports nutrition company reported a 17.2% revenue decline but doubled its Underlying EBITDA. Despite improved margins, operational challenges and market headwinds persist.
SIS
NEUTRALScience in Sport Plc Releases TR-1 Notification
The retailer has released a TR-1 notification regarding changes in major shareholdings.
SIS
NEUTRALScience in Sport Receives Possible Offer Clarification
The retailer provides clarification on a possible offer for the company, but no further details on financial or operational performance.
SIS
NEUTRALScience in Sport Receives Possible Offer from bd-capital
The consumer goods company has received a possible offer from an investment firm, but details are limited.
SIS
GOODScience in Sport Exceeds Market Expectations in FY24
The premium performance nutrition company reported unaudited FY24 results ahead of market expectations, with improved profitability and cash generation, though full-year revenue declined.